The company appointed Michelle Reid, PhD, as vice president of service and support and Anthony Catalano as senior vice president of operations.

Reid was previously the senior director of customer service and support at PGDx, where she built the customer experience teams from the ground up. She was also part of the customer support team at Qiagen. She has a PhD in molecular biology from LaTrobe University in Australia.

Catalano was previously senior director of operations at PerkinElmer. He also served as senior director of manufacturing operations at VisEn Medical from 2001 until its acquisition by PerkinElmer in 2010. He has a Master of Science degree in chemistry from Brandeis University.

IsoPlexis to present data at SITC 2021
IsoPlexis will present data from its IsoLight and IsoSpark platforms at the annual meeting of the Society for Immunotherapy of Cancer (SITC) on November...

IsoPlexis raises $125M in IPO
IsoPlexis completed an initial public offering (IPO) on October 12, closing with $125 million on the sale of approximately 8.3 million shares...

IsoPlexis acquires sequencing methodology IP
IsoPlexis has acquired an intellectual property (IP) portfolio of 86 patents related to DNA and RNA sequencing, which it is integrating into its single-cell...

IsoPlexis launches new personalized lab systems
IsoPlexis has launched two new personalized lab systems, IsoSpark and IsoSpark Duo for high-throughput proteomics.

IsoPlexis launches new COVID-19 proteomics grant challenge
IsoPlexis has unveiled its Single-Cell Proteomics COVID-19 Grant Challenge, which will award 12 of the company's IsoCode or CodePlex chips to two winners...